← back to search
Minjian Qin
Nanjing University of Chinese Medicine
· CN
Area of research
Plant Science · Molecular Biology
Research interest
Research interests include Scale (ratio), Biology, Diversity (politics), Genome, Evolutionary biology, and Benzylisoquinoline.
h-index
—
citations
27
works
2
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
The chromosome-scale assembly of the Notopterygium incisum genome provides insight into the structural diversity of coumarins
Acta Pharmaceutica Sinica B
2024
cited by
14
position: middle
doi
Discovery, Structure, and Mechanism of the (<i>R</i>, <i>S</i>)-Norcoclaurine Synthase for the Chiral Synthesis of Benzylisoquinoline Alkaloids
ACS Catalysis
2023
cited by
13
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Yucheng Zhao
· Shihezi University
2
papers (2023–2024)
Huanying Tang
· China Pharmaceutical University
2
papers (2023–2024)
Ding‐Qiao Xu
· China Pharmaceutical University
2
papers (2023–2024)
Jia‐Yu Xue
· Nanchang University
1
papers (2024–2024)
Yibei Xiao
· Chongqing University
1
papers (2023–2023)
Shiqing Zhang
· Jiangsu University
1
papers (2023–2023)
Yushi Liu
· Dartmouth College
1
papers (2023–2023)
Qien Li
· Beijing University of Chinese Medicine
1
papers (2024–2024)
Libo Zhang
· University of California, Davis
1
papers (2023–2023)
Zixuan Wang
· South China Agricultural University
1
papers (2024–2024)
Qi Qi
· Institute of Pharmacology
1
papers (2024–2024)
Lanlan Sun
· Shihezi University
1
papers (2024–2024)
Latai An
· Qinghai University
1
papers (2024–2024)
Kaixuan Wang
· Beijing Institute of Technology
1
papers (2024–2024)
Xiaobing Wang
· Guangzhou University of Chinese Medicine
1
papers (2023–2023)
Kejin Zhu
· China Pharmaceutical University
1
papers (2023–2023)
Huihui Zeng
· China Pharmaceutical University
1
papers (2024–2024)
Liangliang Han
· China Pharmaceutical University
1
papers (2023–2023)
Lijing Liao
· China Pharmaceutical University
1
papers (2023–2023)
Xiao Guo
· Sun Yat-sen University
1
papers (2024–2024)